NASDAQ
Viking Therapeutics, Inc. (VKTX)
♥ 393 Thanks from members
Viking Therapeutics, Inc. (VKTX) exhibits a mix of wider-than-expected quarterly losses driven by heavy R&D investments and strong bullish market sentiment, with analysts highlighting potential upside targets, positive technical momentum, and persistent timeline risks.